XML 19 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 42,344 $ 38,846
Adjustments to reconcile net income to net cash provided by operating activities:    
Change in fair value of derivatives 9 12
Gain on sale of property 0 (11)
Depreciation and amortization of deferred leasing costs 33,478 32,382
Amortization of deferred debt costs 1,003 1,094
Non cash compensation costs of stock grants and options 1,282 1,136
Provision for credit losses 1,207 1,281
Increase in accounts receivable and accrued income (3,011) (5,340)
Additions to deferred leasing costs (3,721) (4,125)
Increase in prepaid expenses (3,922) (4,022)
(Increase) decrease in other assets (1,365) 1,590
Increase in accounts payable, accrued expenses and other liabilities 3,294 1,816
Increase (decrease) in deferred income (247) 67
Net cash provided by operating activities 70,351 64,726
Cash flows from investing activities:    
Acquisitions of real estate investments (10,341) (4,894)
Additions to real estate investments (11,271) (13,271)
Additions to development and redevelopment projects (23,073) (31,748)
Proceeds from sale of property 0 32
Net cash used in investing activities (44,685) (49,881)
Cash flows from financing activities:    
Proceeds from notes payable 0 46,000
Repayments on notes payable (18,359) (47,007)
Proceeds from revolving credit facility 32,000 15,000
Repayments on revolving credit facility (37,000) (28,000)
Proceeds from construction loan 23,126 26,022
Additions to deferred debt costs 0 (311)
Proceeds from the issuance of:    
Common stock 17,898 11,102
Partnership units 5,144 4,060
Distributions to:    
Series C preferred stockholders (9,281) (9,281)
Common stockholders (29,306) (26,538)
Noncontrolling interests (10,055) (9,098)
Net cash used in financing activities (25,833) (18,051)
Net decrease in cash and cash equivalents (167) (3,206)
Cash and cash equivalents, beginning of period 10,003 12,128
Cash and cash equivalents, end of period $ 9,836 $ 8,922